Effect of vortioxetine vs. escitalopram on plasma BDNF and platelet serotonin in depressed patients.

Progress in Neuro-psychopharmacology & Biological Psychiatry
Anja DvojkovicNela Pivac

Abstract

Escitalopram and vortioxetine are efficacious antidepressants. They directly target serotonin (5-HT) system, but vortioxetine mechanism of action is distinct from the one of selective serotonin reuptake inhibitors (SSRIs). Treatment with SSRIs decrease platelet 5-HT concentration and increase peripheral brain-derived neurotrophic factor (BDNF) levels. Since vortioxetine has a multimodal mechanism of action, it is expected to have a greater effect on circulatory BDNF concentration, compared to conventional antidepressants. This longitudinal study aimed to explore and compare the effects of 4-weeks of treatment with vortioxetine and escitalopram on plasma BDNF and platelet 5-HT concentration in patients with major depressive disorder (MDD). The results revealed that vortioxetine significantly increased plasma BDNF concentration (p = .018) and significantly decreased platelet 5-HT concentration (p < .001). Treatment with escitalopram significantly decreased platelet 5-HT concentration (p < .001), but it did not affect plasma BDNF concentration (p = .379). Response to vortioxetine was not predicted by baseline plasma BDNF or platelet 5-HT concentration, but response to escitalopram was predicted by baseline platelet 5-HT concentrat...Continue Reading

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Mar 1, 1996·Brain Research. Molecular Brain Research·J F Poduslo, G L Curran
Apr 3, 2002·Psychiatry Research·Félicien KaregeJean-Michel Aubry
Dec 28, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Dorotea Mück-SelerAlma Mihaljević-Peles
Aug 19, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Nela PivacAlma Mihaljević-Peles
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Dec 24, 2003·Thrombosis and Haemostasis·Elisabeth Maurer-SpurejKevin Solomons
May 2, 2006·Progress in Neuro-psychopharmacology & Biological Psychiatry·Cigdem AydemirErol Goka
Jul 8, 2010·The International Journal of Neuropsychopharmacology·Anders B KleinSusana Aznar
Jan 22, 2011·Psychiatry Investigation·Bun-Hee Lee, Yong-Ku Kim
Jul 14, 2011·Progress in Neuro-psychopharmacology & Biological Psychiatry·Owen M WolkowitzSynthia H Mellon
Jul 28, 2012·Psychiatry and Clinical Neurosciences·Hoo Rim SongWon-Myong Bahk
Feb 16, 2013·Current Medicinal Chemistry·S Yubero-LahozR de laTorre
Feb 23, 2013·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Per StenkronaJohan Lundberg
Jan 18, 2014·Aging Clinical and Experimental Research·Antonio MartocchiaPaolo Falaschi
Mar 8, 2014·Psychiatry Investigation·Reiji YoshimuraJun Nakamura
Dec 20, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Cécile BétryNasser Haddjeri
Nov 1, 2015·Neuropharmacology·Carl Björkholm, Lisa M Monteggia
Mar 24, 2016·The Journal of Biological Chemistry·Pedro Chacón-FernándezYves-Alain Barde
Jun 8, 2017·International Journal of Molecular Sciences·Maryna PolyakovaMatthias L Schroeter
Dec 23, 2017·Progress in Neuro-psychopharmacology & Biological Psychiatry·N HlavacovaM Franklin
Mar 8, 2018·The International Journal of Neuropsychopharmacology·Fenghua ChenJens R Nyengaard
Jun 13, 2018·Progress in Neuro-psychopharmacology & Biological Psychiatry·André R BrunoniIsabela Martins Benseñor

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.